» Articles » PMID: 35721808

FRT4 Alleviated Obesity by Modulating Gut Microbiota and Liver Metabolome in High-fat Diet-induced Obese Mice

Overview
Journal Food Nutr Res
Date 2022 Jun 20
PMID 35721808
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Obesity has become a global epidemic recognized by the World Health Organization. Probiotics supplementation has been shown to contribute to improve lipid metabolism. However, mechanisms of action of probiotics against obesity are still not clear. FRT4, a probiotic previously isolated from a kind of local yogurt, had good acid and bile salt tolerance and lowered cholesterol .

Objective: This study aimed to evaluate the effect of FRT4 on serum and liver lipid profile, liver metabolomics, and gut microbiota in mice fed with a high-fat diet (HFD).

Design: Mice were fed with either normal diet or HFD for 16 weeks and administered 0.2 mL of 1 × 10 or 1 × 10 CFU/mL dosage of FRT4 during the last 8 weeks of the diet. Cecal contents were analyzed by 16S rRNA sequencing. Hepatic gene expression and metabolites were detected by real-time quantitative polymerase chain reaction (PCR) and metabolomics, respectively.

Results: FRT4 intervention significantly reduced the HFD-induced body weight gain, liver weight, fat weight, serum cholesterol, triglyceride, and alanine aminotransferase (ALT) levels in the liver ( 0.05). Liver metabolomics demonstrated that the HFD increased choline, glycerophosphocholine, and phosphorylcholine involved in the glycerophospholipid metabolism pathway. All these changes were reversed by FRT4 treatment, bringing the levels close to those in the control group. Further mechanisms showed that FRT4 favorably regulated gut barrier function and pro-inflammatory biomediators. Furthermore, FRT4 intervention altered the gut microbiota profiles and increased microbial diversity. The relative abundances of , , , , , , and were significantly upregulated. Finally, Spearman's correlation analysis revealed that several specific genera were strongly correlated with glycerophospholipid metabolites ( 0.05).

Conclusions: These findings suggested that FRT4 had beneficial effects against obesity in HFD-induced obese mice and can be used as a potential functional food for the prevention of obesity.

Citing Articles

BXM2 Treatment Alleviates Disorders Induced by a High-Fat Diet in Mice by Improving Intestinal Health and Modulating the Gut Microbiota.

Cai X, Huang J, Yu T, Guan X, Sun M, Zhao D Nutrients. 2025; 17(3).

PMID: 39940265 PMC: 11820036. DOI: 10.3390/nu17030407.


Probiotics in reducing obesity by reconfiguring the gut microbiota.

Zhang Y, Wang W Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025; 49(7):1042-1051.

PMID: 39788492 PMC: 11495983. DOI: 10.11817/j.issn.1672-7347.2024.240361.


The Gut Microbiota Is Involved in the Regulation of Cognitive Flexibility in Adolescent BALB/c Mice Exposed to Chronic Physical Stress and a High-Fat Diet.

Gonzalez C, Estrada J, Oros-Pantoja R, Colin-Ferreyra M, Benitez-Arciniega A, Soto Pina A Microorganisms. 2025; 12(12.

PMID: 39770745 PMC: 11677384. DOI: 10.3390/microorganisms12122542.


In Vitro Evaluation of Probiotic Activities and Anti-Obesity Effects of EF-1 in Mice Fed a High-Fat Diet.

Cai H, Wang Q, Han X, Zhang H, Wang N, Huang Y Foods. 2025; 13(24.

PMID: 39767037 PMC: 11675756. DOI: 10.3390/foods13244095.


1008 Promotes Reproductive Function and Cognitive Activity in Aged Male Mice with High-Fat-Diet-Induced Obesity by Altering Metabolic Parameters and Alleviating Testicular Oxidative Damage, Inflammation and Apoptosis.

Liu C, Tsai T, Liu T, Chang T, Chen Y, Tsao C Antioxidants (Basel). 2025; 13(12.

PMID: 39765826 PMC: 11673844. DOI: 10.3390/antiox13121498.


References
1.
Mazidi M, Katsiki N, Mikhailidis D, Banach M . Adiposity May Moderate the Link Between Choline Intake and Non-alcoholic Fatty Liver Disease. J Am Coll Nutr. 2019; 38(7):633-639. DOI: 10.1080/07315724.2018.1507011. View

2.
Imajo K, Fujita K, Yoneda M, Shinohara Y, Suzuki K, Mawatari H . Plasma free choline is a novel non-invasive biomarker for early-stage non-alcoholic steatohepatitis: A multi-center validation study. Hepatol Res. 2012; 42(8):757-66. DOI: 10.1111/j.1872-034X.2012.00976.x. View

3.
Yin X, Peng J, Zhao L, Yu Y, Zhang X, Liu P . Structural changes of gut microbiota in a rat non-alcoholic fatty liver disease model treated with a Chinese herbal formula. Syst Appl Microbiol. 2013; 36(3):188-96. DOI: 10.1016/j.syapm.2012.12.009. View

4.
Kong C, Gao R, Yan X, Huang L, Qin H . Probiotics improve gut microbiota dysbiosis in obese mice fed a high-fat or high-sucrose diet. Nutrition. 2019; 60:175-184. DOI: 10.1016/j.nut.2018.10.002. View

5.
Obeid R, Awwad H, Rabagny Y, Graeber S, Herrmann W, Geisel J . Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism. Am J Clin Nutr. 2016; 103(3):703-11. DOI: 10.3945/ajcn.115.121269. View